Renhe Pharmacy Co., Ltd.

Symbol: 000650.SZ

SHZ

6.57

CNY

Market price today

  • 13.8854

    P/E Ratio

  • 4.1656

    PEG Ratio

  • 9.20B

    MRK Cap

  • 0.03%

    DIV Yield

Renhe Pharmacy Co., Ltd. (000650-SZ) Stock Price & Analysis

Shares Outstanding

1399.94M

Gross Profit Margin

0.38%

Operating Profit Margin

0.21%

Net Profit Margin

0.13%

Return on Assets

0.08%

Return on Equity

0.11%

Return on Capital Employed

0.15%

Company general description and statistics

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO:Mr. Qiu Lin Peng
Full-time employees:6062
City:Nanchang
Address:No. 998, Honggu Middle Avenue
IPO:1996-12-10
CIK:

Renhe Pharmacy Co., Ltd. produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, topical lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in 1996 and is headquartered in Nanchang, China.

General Outlook

In simple terms, Renhe Pharmacy Co., Ltd. has 1399.94 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.380% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.207%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.128%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.083% return, is a testament to Renhe Pharmacy Co., Ltd.'s adeptness in optimizing resource deployment. Renhe Pharmacy Co., Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.112%. Furthermore, the proficiency of Renhe Pharmacy Co., Ltd. in capital utilization is underscored by a remarkable 0.155% return on capital employed.

Stock Prices

Renhe Pharmacy Co., Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $6.62, while its low point bottomed out at $6.54. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Renhe Pharmacy Co., Ltd.'s stock market.

Liquidity Ratios

Analyzing 000650.SZ liquidity ratios reveals its financial health of the firm. The current ratio of 437.37% gauges short-term asset coverage for liabilities. The quick ratio (365.17%) assesses immediate liquidity, while the cash ratio (109.20%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio437.37%
Quick Ratio365.17%
Cash Ratio109.20%

Profitability Ratios

000650.SZ profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 20.71% underscores its earnings before tax deductions. The effective tax rate stands at 24.93%, revealing its tax efficiency. The net income per EBT, 62.01%, and the EBT per EBIT, 100.09%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 20.69%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin20.71%
Effective Tax Rate24.93%
Net Income per EBT62.01%
EBT per EBIT100.09%
EBIT per Revenue20.69%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 4.37, it details the span from stock purchase to revenue. The 4 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 516.29% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding365
Days of Inventory Outstanding53
Operating Cycle123.93
Days of Payables Outstanding50
Cash Conversion Cycle74
Receivables Turnover5.16
Payables Turnover7.31
Inventory Turnover6.86
Fixed Asset Turnover4.16
Asset Turnover0.64

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.50, and free cash flow per share, 0.36, depict cash generation on a per-share basis. The cash per share value, 2.22, showcases liquidity position. A payout ratio of 0.43 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.14, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share0.50
Free Cash Flow per Share0.36
Cash per Share2.22
Payout Ratio0.43
Operating Cash Flow Sales Ratio0.14
Free Cash Flow to Operating Cash Flow Ratio0.72
Cash Flow Coverage Ratio93.19
Short Term Coverage Ratio410.01
Capital Expenditure Coverage Ratio3.54
Dividend Paid and Capex Coverage Ratio1.46
Dividend Payout Ratio0.02

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 0.09%, highlights its total liabilities relative to assets. The long-term debt to capitalization, 0.10%, and total debt to capitalization, 0.12%, ratios shed light on its capital structure. An interest coverage of 2823.45 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio0.09%
Long Term Debt to Capitalization0.10%
Total Debt to Capitalization0.12%
Interest Coverage2823.45
Cash Flow to Debt Ratio93.19
Company Equity Multiplier1.33

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 3.68, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.41, reflects the portion of profit attributed to each share. The book value per share, 4.10, represents the net asset value distributed per share, while the tangible book value per share, 3.74, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share3.68
Net Income Per Share0.41
Book Value Per Share4.10
Tangible Book Value Per Share3.74
Shareholders Equity Per Share4.10
Interest Debt Per Share0.01
Capex Per Share-0.16

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 4.41%, indicates top-line expansion, while the gross profit growth, 0.67%, reveals profitability trends. EBIT growth, -8.07%, and operating income growth, -8.07%, offer insights into operational profitability progression. The net income growth, -13.62%, showcases bottom-line expansion, and the EPS growth, -14.58%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth4.41%
Gross Profit Growth0.67%
EBIT Growth-8.07%
Operating Income Growth-8.07%
Net Income Growth-13.62%
EPS Growth-14.58%
EPS Diluted Growth-14.58%
Dividends per Share Growth-50.51%
Operating Cash Flow Growth63.30%
Free Cash Flow Growth277.39%
10-Year Revenue Growth per Share116.57%
5-Year Revenue Growth per Share17.46%
3-Year Revenue Growth per Share-0.50%
10-Year Operating CF Growth per Share505.63%
5-Year Operating CF Growth per Share123.49%
3-Year Operating CF Growth per Share61.88%
10-Year Net Income Growth per Share97.28%
5-Year Net Income Growth per Share32.37%
3-Year Net Income Growth per Share-5.52%
10-Year Shareholders Equity Growth per Share210.75%
5-Year Shareholders Equity Growth per Share67.18%
3-Year Shareholders Equity Growth per Share33.44%
10-Year Dividend per Share Growth per Share202.96%
5-Year Dividend per Share Growth per Share1.11%
3-Year Dividend per Share Growth per Share0.08%
Receivables Growth-10.01%
Inventory Growth-23.88%
Asset Growth10.48%
Book Value per Share Growth8.58%
Debt Growth93.82%
R&D Expense Growth-3.08%
SGA Expenses Growth-3.95%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 5,852,657,056.46, captures the company's total value, considering both debt and equity. Income quality, 1.78, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.01, gauges operational efficiency, while the research and development to revenue, 0.98%, highlights investment in innovation. The ratio of intangibles to total assets, 15.47%, indicates the value of non-physical assets, and capex to operating cash flow, -17.41%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value5,852,657,056.46
Income Quality1.78
Sales General and Administrative to Revenue0.01
Research and Development to Revenue0.98%
Intangibles to Total Assets15.47%
Capex to Operating Cash Flow-17.41%
Capex to Revenue-4.29%
Capex to Depreciation-188.72%
Stock-Based Compensation to Revenue0.34%
Graham Number6.15
Return on Tangible Assets8.90%
Graham Net Net1.93
Working Capital3,416,348,009
Tangible Asset Value5,241,349,659
Net Current Asset Value3,371,003,473
Average Receivables614,865,306
Average Payables187,845,498
Average Inventory529,543,642
Days Sales Outstanding41
Days Payables Outstanding22
Days of Inventory On Hand51
ROIC12.35%
ROE0.10%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.52, and the price to book ratio, 1.52, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.78, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 18.24, and price to operating cash flows, 13.09, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio1.52
Price to Book Ratio1.52
Price to Sales Ratio1.78
Price Cash Flow Ratio13.09
Price Earnings to Growth Ratio4.17
Enterprise Value Multiple9.32
Price Fair Value1.52
Price to Operating Cash Flow Ratio13.09
Price to Free Cash Flows Ratio18.24
Price to Tangible Book Ratio1.51
Enterprise Value to Sales1.14
Enterprise Value Over EBITDA5.19
EV to Operating Cash Flow4.61
Earnings Yield6.63%
Free Cash Flow Yield12.10%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Renhe Pharmacy Co., Ltd. (000650.SZ) on the SHZ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 13.885 in 2024.

What is the ticker symbol of Renhe Pharmacy Co., Ltd. stock?

The ticker symbol of Renhe Pharmacy Co., Ltd. stock is 000650.SZ.

What is company IPO date?

IPO date of Renhe Pharmacy Co., Ltd. is 1996-12-10.

What is company current share price?

Current share price is 6.570 CNY.

What is stock market cap today?

The market cap of stock today is 9197605800.000.

What is PEG ratio in 2024?

The current 4.166 is 4.166 in 2024.

What is the number of employees in 2024?

In 2024 the company has 6062.